Literature DB >> 31372133

Accuracy of BISAP score in prediction of severe acute pancreatitis.

Anum Arif1, Farhat Jaleel2, Khalid Rashid3.   

Abstract

OBJECTIVE: To determine the accuracy of BISAP score in comparison with Ranson's score in detection of severe acute pancreatitis.
METHODS: This cross sectional study was performed in Emergency department and Surgery department of Dow university hospital from January 2015 to December 2015. A total of 206 patients were included. Those diagnosed with acute pancreatitis on the basis of epigastric pain, serum amylase levels more than 300 (more than 3 times normal) and meeting the inclusion criteria were subjected to investigations for Ranson's and BISAP scoring. BISAP score was calculated at 24 hours and Ranson's score both at 24 and 48 hours. A score of > 3 was used to label severe acute pancreatitis according to both scoring systems.
RESULTS: In our study accuracy to predict SAP by BISAP score was 76.2 % and Ranson's score was 82.2%. On the basis of sensitivity, Ranson's scores predicted SAP more accurately than BISAP scores (97.4% vs. 69.2%). Regarding specificity, both scores predicted SAP almost equally (78.4% vs. 77.8%).
CONCLUSION: BISAP score is a valuable tool in predicting severe Acute Pancreatitis in early hours.

Entities:  

Keywords:  BISAP score; Ranson’s score; Severe Acute pancreatitis

Year:  2019        PMID: 31372133      PMCID: PMC6659069          DOI: 10.12669/pjms.35.4.1286

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


INTRODUCTION

Acute pancreatitis (AP) is a common disorder with substantial burden on the health-care system. AP accounts for 210,000 hospital admissions per annum in the United States.1,2 Recent studies show the incidence of AP varies between 4.9 and 73.4 cases per 100,000 worldwide.3,4 An increase in the annual incidence for AP has been observed in most recent studies. It is a complex process in which pancreatic enzyme activation causes local pancreatic damage, resulting in an acute inflammatory response.5 The individual patient’s response to pancreatic injury is highly variable and often unpredictable.5 Most of the time auto digestion of pancreas is mild and self-limiting but in 20% to 30% cases it develop severe disease that can progress to SIRS, MODS and death.6 According to Atlanta classification (2012) severe acute pancreatitis is defined as acute pancreatitis with persistent organ failure more than > 48 hours. A wide range of mortality 20% to 60% has been reported in severe acute pancreatitis.7 Many scoring systems have been developed for the detection of severe acute pancreatitis including Ranson’s score, APACHE-II score, CTSI score, MOSS and GLASGOW score.8-10 The Ranson’s score has been used over three decades. It is moderately accurate in classifying patients in terms of severity, but has the disadvantage of requiring a full 48 hours to be completed, missing a potentially valuable early therapeutic window.8,11 BISAP score is a newly developed scoring system containing data that can be evaluated at the time of admission which are accurate in predicting patient’s outcome within 24 hours.12 The international studies comparing both showed varied results. One of the study shows that the sensitivity of severity acute pancreatitis predicted by BISAP was 74.2%, specificity 68.3% positive predictive value 63.4% and negative predictive value 77.8%6 whereas in another study sensitivity is 38.6%, specificity 93.2%, positive predictive value 59.1% and negative predictive value 85.6%.7 Ranson’s score requires lots of variables raising cost of complete diagnosis and management whereas BISAP score has less variables which are cost effective and can be done in emergency setting. As the above mentioned studies results are variable, the rationale of this study was to determine BISAP score in emergency setting. If results prove to be in favor of BISAP score than it can help in early diagnosis of severe acute pancreatitis, preventing complications and overall mortality can be reduced. The objective of this study was to determine the accuracy of BISAP score in comparison with Ranson’s score in detection of severity of acute pancreatitis in a tertiary care hospital.

METHODS

This cross sectional study was performed in Emergency department and Surgery department of Dow university hospital from January 2015 to December 2015 after the approval from Research and Training monitoring cell of CPSP. A total of 206 patients were included in the study. The sample size was calculated by taking prevalence 25% and 6%. Informed and written consents were taken from all patients. Inclusion criteria contained both males and females, age range between 20 to 50 years, patient presenting within 48 hours of onset of pain (VAS > 5), raised serum amylase levels (more than or equal to 300 IU) within 48 hours of epigastric or upper abdominal pain. Patients who refused to participate in the study, those presenting after 48 hours of onset of pain, patients with other causes of hyperamylasemia and with carcinoma pancreas were excluded from study. Bedside Index of Severity of Acute Pancreatitis (BISAP) was calculated. It includes 5 variables. Blood urea nitrogen levels > 25 mg/dl, impaired mental status or GCS < 15, SIRS, age > 60 years and pleural effusion on imaging. Each variable was granted a score of 1. All patients were subjected to investigations including CBC, LDH, SGOT, RBS, BUN and Chest x-ray. Age SIRS, GCS was recorded to assess the BISAP score and Ranon’s score at 24 hours. Patients were admitted and further evaluated with investigations required for assessment of 48 hours Ranson’s score which included CBC (to asses fall in Hematocrit), BUN, serum calcium, ABGs and fluid deficit. Final agreement between the scores was evaluated at 48 hours. All demographics and outcome variables were entered into the proforma. Outcome variable of this study were age, duration of symptoms, Ranson score and BISAP score. All patients enrolled were diagnosed and classified as mild, moderately severe and SAP according to latest Atlanta classification. SAP was characterized by persistent organ failure for more than 48 hours. A cut off score ≥ 3 was taken to categorize SAP according to Ranson and BISAP score at 24 and 48 hours.

Statistical Analysis

All data was entered in Statistical Package for Social Science (SPSS) software, Version 16. Mean and standard deviation were calculated for quantitative variables. Frequency and percentages were computed for qualitative variables. Effect modifiers like age, gender, baseline pain were controlled by stratification. Associations between SAP and age and gender were measured using Chi-square analysis. Further, to see the accuracy for both scoring systems in predicting SAP, Receiver Operating Characteristics (ROC) analysis was also performed. Overall accuracy in predicting SAP, sensitivity, specificity, positive predictive value (+PV), negative predictive value (-PV) were calculated. To check the strength of agreement between standard classified diagnosis using Atlanta classification and Ranson’s and BISAP scores, Kappa coefficient of agreement was also calculated. To observe the accuracy for both systems, Area under the curves (AUC) with 95% confidence intervals (CI) were also calculated, and curves were plotted against standard diagnosis by Atlanta classification taken as reference line. All the analyses were performed by using the Statistical Package for Social Science (SPSS) software, Version 16, and Receiver Operating Characteristics (ROC) analysis was performed using software STATA version 8.1. For all analysis p-value < 0.05 was takes as significant. Receiver operation characteristic (ROC) curve of Ranson’s scores in predicting SAP.

RESULTS

The study included a total of 206 patients of Acute Pancreatitis (AP) from Emergency department and Surgery department of Dow University Hospital on the patient fulfilling the inclusion criteria after taking informed consent. According to Atlanta classification, diagnosed patients with severe AP were found 18.9% (n=39), and patients with mild and moderately severe AP were 81.1% (n=167). Table-I: Describes the characteristics of study participants. The observed BISAP and Ranson’s scores distribution was also reported in Table-I.
Table I

Description of patient’s characteristics (n=206).

Study variablesmean ± SD
Age in years35.25 ± 8.29
Duration of symptoms (hrs.)10.93 ± 9.94
Baseline pain score (VAS)6.63 ± 1.31

n (%)

Severity of pain
 Moderate110 (53.4%)
 Severe96 (46.6%)
Age groups
 20 - 2961 (29.6%)
 30 - 3974 (35.9%)
 40 - 5071 (34.5%)
Sex
 Male81 (39.3%)
 Female125 (60.7%)
BISAP score
 156 (27.2%)
 286 (41.7%)
 334 (16.5%)
 430 (14.6%)
Ranson’s score
 165 (31.6%)
 267 (32.5%)
 320 (9.7%)
 428 (13.6%)
 5-726 (12.6%)

BISAP: bedside index of severity in acute pancreatitis

Description of patient’s characteristics (n=206). BISAP: bedside index of severity in acute pancreatitis Receiver operation characteristic (ROC) curve of BISAP scores in predicting SAP. Cutoff of ≥3 score values was taken as criteria for SAP. For BISAP, 31.10% (n=64) patients were found as SAP, whereas 35.90% (n=74) patients had SAP condition according to Ranson’s score. Characteristics of patients with score ≥3 are shown in Table-II. Comparison between Ranson’s and BISAP score in predicting SAP is shown in Table-III.
Table II

Characteristics of patients having score ≥ 3 (n=206).

CharacteristicsBISAP score ≥ 3p-value

NoYes

n (%)n (%)
Age groups
20 - 2935 (24.6)26 (40.6)0.017
30 - 3950 (35.2)24 (37.5)
40 - 5057 (40.1)14 (21.9)
Sex
Male52 (36.6)29 (45.3)0.237
Female90 (63.4)35 (54.7)

Ranson score ≥ 3p-value

NoYes

n (%)n (%)

Age groups
20 - 2924 (18.2)37 (50.0)< 0.01
30 - 3953 (40.2)21 (28.4)
40 – 5055 (41.7)16 (21.6)
Sex
Male43 (32.6)38 (51.4)< 0.01
Female89 (67.4)36 (48.6)

Comparison between Ranson’s and BISAP score in predicting SAP is shown in Table-III.

Table III

Comparison of BISAP with Ranson’s score in predicting SAP at ≥ 3 (n=206).

AccuracySensitivitySpecificity+PV-PVAUC (95% CI)Measure of agreement Kappa (95% CI)
Ranson ≥ 382.0%97.4%78.4%51.3%99.2%0.92 (0.87 - 0.97)0.56 (0.44 - 0.67) < 0.001
BISAP ≥ 376.2%69.2%77.8%42.2%91.5%0.73 (0.64 - 0.82)0.37 (0.23 - 0.50) < 0.001

BISAP: bedside index of severity in acute pancreatitis, SAP: severe acute pancreatitis, +PV: positive predictive value, -PV: negative predictive value, AUC: Area under curve, CI: confidence intervals

Characteristics of patients having score ≥ 3 (n=206). Comparison between Ranson’s and BISAP score in predicting SAP is shown in Table-III. Comparison of BISAP with Ranson’s score in predicting SAP at ≥ 3 (n=206). BISAP: bedside index of severity in acute pancreatitis, SAP: severe acute pancreatitis, +PV: positive predictive value, -PV: negative predictive value, AUC: Area under curve, CI: confidence intervals

DISCUSSION

Accurate and quick prediction of SAP is important in order to decrease mortality rate which is around 20% to 60%.7,11 Many scoring systems have been developed to determine the severe acute pancreatitis early so that better care can be provided to patients and mortality can be decreased. An ideal scoring system should be simple, safe, cheap and less time consuming. BISAP score is one of the newer scoring systems to predict the severity of acute pancreatitis. It has got 5 variable that can be done quickly in emergency department within 24 hours. In this study we determined the accuracy of BISAP score in comparison with Ranson score in predicting the SAP. Female predominance is noted in most of the studies which is confirmed in our study too6,8,13 whereas no difference is reported between either sex in certain studies.7,14 Out of these SAP was seen in 54.7% and 48.6% of females according to BISAP and Ranson’s score respectively. Mean age of patients with acute pancreatitis was 35.25 ± 8.29 years (range 20 – 50) with 35.9% of the population in age range between 30 to 39 years. However majority of the patients fall in 4th and 5th decade of life according to Shabbir S et al13 and between 21-30 years according to Khanna AK et al.6 No difference of age group was reported by Chen L et al.7 In our study, out of 206 patients, total number of 18.9% (n=39) patients has SAP according to Atlanta classification. We found that 38 out of 39 patients had SAP according to Ranson score therefore sensitivity of 97.4% whereas 27 out of 39 patients has SAP according to BISAP score therefore sensitivity of BISAP score was 69.2%. It is comparable to a study conducted by Cho JH et al. according to which sensitivity of Ranson and BISAP score was 85.7 % and 61.9 % respectively.15 This is in contrast to BISAP score sensitivity of 58.33% reported by Kim BG et al.16 With regard to mortality, 10 patients needed ICU admission, five had sepsis, four with pancreatic necrosis and one with MODS. Out of them there were 6 mortalities and all had Ranson score of > 3 and 4 had BISAP score of > 3. The accuracy of BISAP score for predicting SAP is 76.2 %. Kappa value is 0.34 showing slight agreement between the the two whereas accuracy of Ranson’s score for predicting SAP is 82.0 % kappa value 0.56 showing fair agreement between the two. This is in comparison with the study reported by Khana AK et al6 as in his study accuracy of BISAP and Ranson;s score was 70.8 % and 80.6 % respectively. Slight different results are observed in study conducted by Kim B G et al. in which accuracy of BISAP and Ranson’s score for predicting severe acute pancreatitis was 84% and 94 % respectively which is far greater than accuracy of serum procalcitonin reported in the same study as 58%.16

Limitations of the study

It’s a single center study with small sample size. A multicenter validation study is required to confirm our results and second our observations of BISAP score in severe acute pancreatitis.

CONCLUSION

BISAP score is a valuable tool in predicting severity of severe acute pancreatitis being simple, easy and cost effective. The assessment is completed in 24 hours that allows early decision making and prompt management. Accuracy of BISAP and Ranson’s score is comparable.
  16 in total

Review 1.  AGA Institute technical review on acute pancreatitis.

Authors:  Chris E Forsmark; John Baillie
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

2.  A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis.

Authors:  Vikesh K Singh; Bechien U Wu; Thomas L Bollen; Kathryn Repas; Rie Maurer; Richard S Johannes; Koenraad J Mortele; Darwin L Conwell; Peter A Banks
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 3.  Risk assessment in acute pancreatitis.

Authors:  R Mofidi; P V Patil; S A Suttie; R W Parks
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

4.  Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis.

Authors:  Georgios I Papachristou; Venkata Muddana; Dhiraj Yadav; Michael O'Connell; Michael K Sanders; Adam Slivka; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2009-10-27       Impact factor: 10.864

5.  Evaluation of the BISAP score in predicting severity and prognoses of acute pancreatitis in Chinese patients.

Authors:  Lifen Chen; Guomin Lu; Qunyan Zhou; Qiang Zhan
Journal:  Int Surg       Date:  2013 Jan-Mar

6.  Usefulness of the Bedside Index for severity in acute pancreatitis in the early prediction of severity and mortality in acute pancreatitis.

Authors:  Young-Seok Cho; Hyung-Keun Kim; Eun-Chul Jang; Ju-Ok Yeom; Sun-Young Kim; Ji-Youn Yu; Yun-Ji Kim; Kyong-Rock Do; Sung-Soo Kim; Hiun-Suk Chae
Journal:  Pancreas       Date:  2013-04       Impact factor: 3.327

7.  Burden of gastrointestinal disease in the United States: 2012 update.

Authors:  Anne F Peery; Evan S Dellon; Jennifer Lund; Seth D Crockett; Christopher E McGowan; William J Bulsiewicz; Lisa M Gangarosa; Michelle T Thiny; Karyn Stizenberg; Douglas R Morgan; Yehuda Ringel; Hannah P Kim; Marco Dacosta DiBonaventura; Charlotte F Carroll; Jeffery K Allen; Suzanne F Cook; Robert S Sandler; Michael D Kappelman; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

8.  American College of Gastroenterology guideline: management of acute pancreatitis.

Authors:  Scott Tenner; John Baillie; John DeWitt; Santhi Swaroop Vege
Journal:  Am J Gastroenterol       Date:  2013-07-30       Impact factor: 10.864

Review 9.  Risk and markers of severe acute pancreatitis.

Authors:  Georgios I Papachristou; Gilles Clermont; Arun Sharma; Dhiraj Yadav; David C Whitcomb
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

10.  A comparison of the BISAP score and serum procalcitonin for predicting the severity of acute pancreatitis.

Authors:  Byung Geun Kim; Myung Hwan Noh; Choong Heon Ryu; Hwa Seong Nam; Su Mi Woo; Seung Hee Ryu; Jin Seok Jang; Jong Hun Lee; Seok Ryeol Choi; Byeong Ho Park
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

View more
  4 in total

Review 1.  Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2020-01-04       Impact factor: 5.923

2.  Clinical utility of the pancreatitis activity scoring system in severe acute pancreatitis.

Authors:  Zetao Yu; Qingqiang Ni; Peng Zhang; Hongtao Jia; Faji Yang; Hengjun Gao; Huaqiang Zhu; Fangfeng Liu; Xu Zhou; Hong Chang; Jun Lu
Journal:  Front Physiol       Date:  2022-08-22       Impact factor: 4.755

Review 3.  Diagnosis and Treatment of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; R Shane Tubbs; Michał Podgórski; Justyna Dłubek-Ruxer; Łukasz Olewnik
Journal:  Diagnostics (Basel)       Date:  2022-08-15

Review 4.  The Pancreas and Known Factors of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; Piotr Karauda; R Shane Tubbs; Konrad Kurtys; Łukasz Olewnik
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.